Overview

Definition:
-Marfan syndrome is an autosomal dominant genetic disorder affecting the connective tissues throughout the body
-It is caused by mutations in the FBN1 gene, which encodes fibrillin-1, a protein essential for the structure and elasticity of connective tissues.
Epidemiology:
-The prevalence is estimated to be between 1 in 3,000 to 1 in 5,000 live births worldwide
-It affects both sexes and all ethnic groups equally
-Approximately 75% of cases are inherited, while 25% arise from spontaneous new mutations.
Clinical Significance:
-Marfan syndrome has significant implications for pediatric health, primarily due to its potential to cause life-threatening cardiovascular complications, particularly aortic root dilation and dissection
-It also affects skeletal, ocular, pulmonary, and dural systems, requiring multidisciplinary management and surveillance.

Clinical Presentation

Symptoms:
-Tall stature
-Arachnodactyly (long, slender fingers and toes)
-Pectus excavatum or pectus carinatum
-Scoliosis or kyphosis
-Lens dislocation (ectopia lentis)
-Mitral valve prolapse
-Aortic root dilation
-Shortness of breath
-Chest pain.
Signs:
-Positive wrist sign (thumb and fifth finger overlap when encircling the contralateral wrist)
-Positive thumb sign (thumb protrudes beyond the ulnar border of the palm)
-High-arched palate with crowded teeth
-Joint hypermobility
-Striae (stretch marks) not associated with weight changes.
Diagnostic Criteria:
-Diagnosis is typically made using the revised Ghent nosology criteria, which integrate family history, clinical manifestations, and genetic testing
-Key criteria include aortic root dilation (Z-score >= 2), ectopia lentis, and systemic score based on various phenotypic features.

Diagnostic Approach

History Taking:
-Detailed family history of cardiovascular events (e.g., aortic dissection, aneurysm), sudden death, or known connective tissue disorders
-Personal history of scoliosis, joint hypermobility, visual problems, or pneumothorax
-Inquiry about rapid growth spurts or skeletal pain.
Physical Examination:
-Systematic assessment of skeletal features (height, arm span, wrist/thumb signs, joint laxity, spinal curvature)
-Cardiovascular examination focusing on murmurs (mitral regurgitation, aortic regurgitation) and peripheral pulses
-Ocular examination for lens position
-Palpation for striae and assessment of lung sounds.
Investigations:
-Echocardiography: serial measurements of aortic root diameter (Z-score is crucial for monitoring)
-Electrocardiogram (ECG) and Holter monitoring: to detect arrhythmias or conduction abnormalities
-MRI or CT angiography: for detailed evaluation of the aorta, especially if echocardiography is limited or suggests significant dilation
-Genetic testing for FBN1 mutations: confirms diagnosis and aids in family screening
-Skeletal survey: to assess scoliosis and other skeletal abnormalities
-Slit-lamp examination: for ectopia lentis.
Differential Diagnosis:
-Loeys-Dietz syndrome, Ehlers-Danlos syndrome (vascular type), familial thoracic aortic aneurysm and dissection (FTAAD), mass effect syndromes, simple marfanoid habitus
-Distinguishing features include specific gene mutations, pattern of organ involvement, and characteristic physical findings.

Management

Initial Management:
-Multidisciplinary team approach involving pediatric cardiologists, geneticists, ophthalmologists, orthopedic surgeons, and pulmonologists
-Regular surveillance and early intervention are key.
Medical Management:
-Beta-blockers (e.g., propranolol, atenolol): to reduce heart rate and contractility, decreasing shear stress on the aortic wall
-Angiotensin II receptor blockers (ARBs, e.g., losartan): shown to be effective in reducing aortic root growth in some studies, often used in conjunction with or as an alternative to beta-blockers
-Regular BP monitoring and control are essential.
Surgical Management:
-Aortic root replacement surgery: indicated for severe aortic root dilation (typically Z-score >= 3, or rapid progression), aortic dissection, or significant aortic regurgitation
-Valve-sparing root replacement is preferred when feasible to preserve aortic valve function
-Prophylactic surgery may be considered in select cases based on imaging and risk factors.
Supportive Care:
-Ophthalmologic care: regular monitoring for ectopia lentis, glaucoma, and retinal detachment
-Orthopedic management: bracing or surgery for scoliosis, management of joint pain
-Pulmonary care: monitoring for pneumothorax, appropriate management of asthma or other respiratory issues
-Psychological support for patients and families.

Aortic Root Monitoring

Monitoring Frequency:
-Annual echocardiograms are recommended for all patients with Marfan syndrome
-More frequent monitoring (e.g., every 6 months) may be necessary for children with known significant aortic dilation, rapid growth, or those on less effective medical therapy.
Echocardiographic Parameters:
-Measurement of the aortic root at the sinuses of Valsalva, sinotubular junction, and ascending aorta
-Calculation of Z-scores based on age and body surface area is critical
-Assessment of aortic regurgitation severity and LV dimensions/function.
Indications For Intervention:
-Surgical intervention is typically considered when the aortic root diameter reaches 5.0-5.5 cm in adults, or for children with a Z-score of 2.0 or greater with a rapidly progressive dilation, or when aortic dissection occurs
-Individualized decision-making is paramount.
Genetic Screening:
-First-degree relatives of individuals with Marfan syndrome should undergo evaluation, including cardiovascular screening
-Genetic testing can confirm diagnosis and aid in risk stratification for family members.

Sports Participation

Risk Assessment:
-Athletic participation in children with Marfan syndrome requires careful risk assessment, particularly regarding cardiovascular status
-The primary concern is the risk of aortic dissection or rupture during strenuous physical activity.
Guidelines: Current guidelines, such as those from the American Heart Association (AHA) and the American College of Cardiology (ACC), generally recommend restricting participation in competitive, high-intensity, or contact sports for individuals with significant aortic root dilation (e.g., Z-score > 2.0) or other cardiovascular abnormalities.
Recommended Activities:
-Low-intensity, non-competitive activities are generally considered safe
-These may include recreational swimming, walking, golf, doubles tennis (with modified exertion), and light strength training
-Avoidance of activities involving sudden bursts of maximal exertion, heavy lifting, and rapid changes in direction is advised.
Individualized Approach:
-Decision-making should be individualized and based on a thorough cardiovascular evaluation, the severity of aortic dilation, family history, and the specific demands of the sport
-Close collaboration between the patient, family, and medical team is essential
-Regular reassessment of cardiovascular status is necessary.

Prognosis

Factors Affecting Prognosis:
-The prognosis is largely determined by the presence and severity of cardiovascular complications, especially aortic root dilation and dissection
-Early diagnosis, consistent medical management, and timely surgical intervention significantly improve outcomes.
Outcomes:
-With modern management strategies, life expectancy for individuals with Marfan syndrome has significantly improved, approaching that of the general population in well-managed cases
-However, cardiovascular complications remain the leading cause of morbidity and mortality.
Follow Up:
-Lifelong follow-up is essential, with regular cardiovascular imaging (echocardiography), ophthalmologic evaluations, and orthopedic assessments
-Monitoring for new or worsening symptoms and adherence to medical therapy are crucial for long-term well-being.

Key Points

Exam Focus:
-Ghent nosology criteria for diagnosis
-Key echocardiographic parameters for aortic root monitoring (Z-score)
-Indications for beta-blockers and ARBs
-Surgical indications for aortic root repair
-Cardiovascular risks associated with sports participation in Marfan syndrome.
Clinical Pearls:
-Always measure the aortic root Z-score, not just absolute diameter
-Consider ARBs alongside or instead of beta-blockers for aortic root dilation
-Educate families about the importance of annual cardiac screening and safe sports participation
-Remember the multisystemic nature of Marfan syndrome.
Common Mistakes:
-Underestimating the risk of aortic dissection in asymptomatic individuals
-Inconsistent follow-up of aortic root diameter
-Inappropriate recommendations regarding sports participation without thorough cardiac evaluation
-Over-reliance on family history alone for diagnosis in de novo mutations.